• XRHealth

  Participated · Equity · Jan 2024

  XRHealth operates state-of-the-art therapeutic care Virtual Rooms built on proprietary FDA- and CE-registered medical extended reality (XR) technology. The platform integrates immersive XR technology, licensed clinicians, and advanced data analytics to provide remote rehabilitation, cognitive assessment and training, and pain management. XRHealth works with several U.S. healthcare providers, hospitals, and rehabilitation centers to deliver treatments in patients' homes. Led by CEO Eran Orr, the company was founded in 2016 and is headquartered in Boston, Massachusetts, with an R&D center in Tel-Aviv, Israel. The company plans to use the new funding to complete its merger with Amelia Virtual Care and to further develop an AI-based clinician to treat mental health conditions and guide physical and occupational therapy programs. XRHealth raised $6M in the reported funding round. XRHealth provides an FDA- and CE-registered extended reality (XR) platform that brings patient care into the Metaverse via therapeutic Virtual Rooms. The company combines proprietary medical virtual and augmented reality technology with licensed clinicians and advanced data analytics to deliver remote rehabilitation, cognitive assessment and pain-management solutions. XRHealth offers a variety of patent-pending therapeutic solutions spanning rehabilitation services, cognitive training and pain management. Following a $10M funding round, the company intends to use the proceeds to expand virtual healthcare treatment in the Metaverse. Founded in 2016 and led by CEO Eran Orr, XRHealth works with several U.S. healthcare providers, hospitals and rehabilitation centers. The company is based in Boston and maintains an R&D center in Tel-Aviv, Israel. XRHealth offers virtual treatment delivered by licensed clinicians using FDA-registered VR applications combined with data analytics. The company operates a virtual clinic that treats patients at home while they are remotely monitored by an XRHealth clinician. Its VR/AR platform includes real and virtual environments, games, and exercises addressing motor, cognitive, and physical symptoms across specialties such as physical, occupational and speech-language therapy, pain and ADHD management, memory/cognitive training, and post-COVID-19 rehabilitation. XRHealth is ISO certified, FDA registered and HIPAA compliant. The company intends to use the new funding to expand sales and marketing to bring VR/AR therapy to patients in the U.S., Australia and Israel. Led by Eran Orr, XRHealth is focused on scaling clinical deployment of its telehealth offerings. XRHealth is a VR telemedicine platform that offers FDA-registered software for remote treatment and rehabilitation. Its clinical applications include rehabilitation for back, shoulder and neck injuries, cognitive training and stress relief, and the company is courting developers to build additional therapeutic content. XRHealth also offers social features to run physician-moderated VR support groups and a web portal for medical professionals to track patient progress and challenges. The company rents hardware directly to consumers, ships Vive Focus and Pico Neo 2 headsets (and supports Oculus hardware), and during COVID-19 is waiving rental fees and working with insurers to waive co-pays. XRHealth said it expected to have more than 500 trained clinicians operating its software by the end of the month, indicating early clinician adoption. Financially, TechCrunch reports XRHealth raised $7 million in new funding, bringing total capital raised to $15 million, including a $4 million seed round in late 2018.

No current team members are available.